Literature DB >> 15849061

Fusarium osteomyelitis: case report and review of the literature.

Miguel Sierra-Hoffman1, Sofya Paltiyevich-Gibson, John L Carpenter, Douglas L Hurley.   

Abstract

We present a case of Fusarium osteomyelitis attributed to innocuous trauma in a patient with significant peripheral vascular disease and diabetes mellitus type 2. Fusarium species have been reported to cause an increasing number of infections, particularly in severely immunocompromized patients. Colonization of normal skin has also been reported. To the best of the author's knowledge, there are 5 cases of Fusarium osteomyelitis described in English-language literature. There is also a report with little detail of Fusarium infection involving bone in 3 patients with hematologic malignancy. We tabulated the pertinent facts of the 5 detailed cases and compared them to ours. Early diagnosis requires some suspicion of invasive fungal infection. Tissue culture and pathologic examination are necessary for definitive diagnosis and to distinguish infection from colonization. Therapy includes antifungal drugs and aggressive surgical debridement, and even when these modalities are readily implemented the outcome may not be optimal because of the angioinvasive character of the organism.

Entities:  

Mesh:

Year:  2005        PMID: 15849061     DOI: 10.1080/00365540410021036

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  13 in total

1.  An Unusual Etiology for Osteomyelitis in an Immunocompetent Host.

Authors:  Meredith Schade; Matthew R England
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

2.  Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification.

Authors:  Srilatha Edupuganti; Nadine Rouphael; Aneesh Mehta; Molly Eaton; John G Heller; Adam Bressler; Mary Brandt; Kerry O'Donnell
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

3.  Successful use of locally applied polyhexamethylene biguanide as an adjunct to the treatment of fungal osteomyelitis.

Authors:  Genevieve Walls; Lisa Noonan; Elizabeth Wilson; David Holland; Simon Briggs
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  [Invasive mycoses and trauma].

Authors:  Alexandra Obradovic; Stefan Hajdu; Elisabeth Presterl
Journal:  Wien Med Wochenschr       Date:  2007

5.  Pseudallescheria fusoidea, a new cause of osteomyelitis.

Authors:  Mark D Lindsley; Josep Guarro; Raed N Khairy; JoaAnna Williams; Naureen Iqbal; Preeti Pancholi
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

Review 6.  Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: a case report and review of the literature.

Authors:  Pinaki Dutta; A Premkumar; Arunaloke Chakrabarti; Viral N Shah; Arnanshu Behera; Deepankar De; Shivaprakash M Rudramurthy; Anil Bhansali
Journal:  Mycopathologia       Date:  2013-06-30       Impact factor: 2.574

Review 7.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 8.  Fusarium infection: report of 26 cases and review of 97 cases from the literature.

Authors:  Maged Muhammed; Theodora Anagnostou; Athanasios Desalermos; Themistoklis K Kourkoumpetis; Herman A Carneiro; Justin Glavis-Bloom; Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

9.  Intracranial fusarium fungal abscess in an immunocompetent patient: case report and review of the literature.

Authors:  Asa Peterson; Martin H Pham; Brian Lee; Deborah Commins; Joseph Cadden; Steven L Giannotta; Gabriel Zada
Journal:  J Neurol Surg Rep       Date:  2014-11-12

10.  Fusarium Osteomyelitis in a Patient With Pearson Syndrome: Case Report and Review of the Literature.

Authors:  Rachael M Hiebert; Robert C Welliver; Zhongxin Yu
Journal:  Open Forum Infect Dis       Date:  2016-10-07       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.